Diplomat Specialty Pharmacy® and Diplomat Specialty Infusion Group® are joining the Optum® family.

To learn more about what this means for you, visit our FAQ pages:

Specialty Pharmacy FAQ  •  Infusion Pharmacy FAQ


Know your patients’ specialty infusion outcomes.

BioFeedback, an outcomes-reporting program from Diplomat Specialty Infusion Group, enables the right interventions at the right time. As pharmacy spend shifts toward specialty, it’s more important than ever to understand how complex therapies are working in the real world. BioFeedback keeps every member of the healthcare team informed.

Developed in consultation with leading medical experts, BioFeedback includes:

  • Disease- and therapy-specific reports
  • Routine, trended reports
  • Post-infusion reports for IVIG

BioFeedback offers reports for these conditions:

  • Alpha-1 antitrypsin deficiency
  • Autoimmune neuropathies (immune globulin)
  • Hereditary angioedema
  • Primary immunodeficiencies (immune globulin)

To request more information, please complete the form.

By completing this form, I agree that Diplomat entities may contact me about products, programs, and services. This may include marketing or other communications by mail, phone, email, or other methods. I understand that I can opt out of these communications at any time.

Please don’t use this form to share anything you wish to keep confidential — including private health information. Some personal details might be required (such as your name, address, and email) so that we can respond to your submission. Diplomat will not share this information with unaffiliated third parties.